New Jersey · 2026-2027 Regular Session · Bill
S 4089: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 4089 is a bill introduced in the New Jersey Senate on May 4, 2026. According to its official title, it concerns: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer. Primary sponsor: Raj Mukherji (Democratic), Joe Vitale (Democratic). Most recent recorded action (May 4, 2026): Introduced in the Senate, Referred to Senate Commerce Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Raj Mukherji | Primary sponsor | Democratic | Senate | 32 |
| Joe Vitale | Primary sponsor | Democratic | Senate | 19 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced in the Senate, Referred to Senate Commerce Committee